Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients

Y. Debie, J. Van Audenaerde, T. Vandamme, L. Croes, L-A. M. N. Teuwen, L. Verbruggen, G. Vanhoutte, E. Marcq, D. Le Blon, B. Peeters, M. E. Goossens, K. Ariën, S. Anguille, E. Smits, C. Vulsteke, E. Lion, M. Peeters, P. A. van Dam

Research output: Contribution to journal › Conference abstract in journal

Fingerprint

Dive into the research topics of 'Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences